INVA (Innoviva, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Innoviva, Inc. Common Stock (INVA) is a publicly traded Healthcare sector company. As of May 21, 2026, INVA trades at $22.62 with a market cap of $1.61B and a P/E ratio of 3.12. INVA moved +2.35% today. Year to date, INVA is +11.03%; over the trailing twelve months it is +18.42%. Its 52-week range spans $16.52 to $25.15. Analyst consensus is buy with an average price target of $34.60. Rallies surfaces INVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns INVA stock?
Hedge funds tracked by Rallies that own INVA include Exoduspoint Capital. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Innoviva, Inc. Common Stock.
INVA Key Metrics
Key financial metrics for INVA
Metric
Value
Price
$22.62
Market Cap
$1.61B
P/E Ratio
3.12
EPS
$7.20
Dividend Yield
0.25%
52-Week High
$25.15
52-Week Low
$16.52
Volume
24
Avg Volume
0
Revenue (TTM)
$420.69M
Net Income
$504.34M
Gross Margin
73.73%
Top Hedge Funds Holding INVA
Exoduspoint Capital holds 97.28K shares of INVA, changed -29.86% as of Mar 31, 2025.
Hedge funds tracked by Rallies that own INVA include Exoduspoint Capital. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Innoviva, Inc. Common Stock.
Does Rallies show 13F holders for INVA?
Yes. Rallies tracks hedge fund and 13F ownership data for INVA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is INVA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INVA. It does not provide personalized investment advice.